SCHEMBL23387016

SCHEMBL23387016

COc1c(Cl)cc(Cl)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPK1 P28482 2/20 0.58
HSD11B1 P28845 1/20 0.47
SLC2A1 P11166 1/20 0.47
CYP1A2 P05177 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
CYP2C19 P33261 2/20 0.46
NPSR1 Q6W5P4 1/20 0.45
CYP2A6 P11509 2/20 0.44
POLB P06746 1/20 0.42
MCL1 Q07820 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
IDO1 P14902 2/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12603984 0.83 MAPK1 (0.54) ALDH1A1SMN1; SMN2KDM4EMAPK1HSD11B1
SCHEMBL25185870 0.79 KDM4E (0.48) ALDH1A1SMN1; SMN2KDM4EMAPK1HSD11B1
SCHEMBL10391368 0.77 MCL1 (0.66) ALDH1A1SMN1; SMN2KDM4EMAPK1HSD11B1
SCHEMBL10391302 0.76 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KDM4EMAPK1MEN1
SCHEMBL9108463 0.76 DRD3 (0.48) ALDH1A1SMN1; SMN2KDM4EMAPK1SLC2A1
SCHEMBL8967049 0.76 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KDM4EMAPK1SLC2A1
SCHEMBL29366129 0.75 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EMAPK1CYP1A2
SCHEMBL52405 0.75 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EMAPK1CYP1A2
SCHEMBL19612347 0.75 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4EMAPK1HSD11B1
SCHEMBL7461874 0.75 MAPT (0.41) ALDH1A1SMN1; SMN2KDM4EMAPK1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780935-B2 Mutant antibodies and conjugation thereof PFIZER HEALTHCARE IRELAND (IE) 2023-10-10 US disclosed
US-20210147576-A1 MUTANT ANTIBODIES AND CONJUGATION THEREOF PFIZER HEALTHCARE IRELAND (IE) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147576-A1 MUTANT ANTIBODIES AND CONJUGATION THEREOF IGLV6-57, IGSF11, F13B ALDH1A1 3691/4885SMN1; SMN2 2828/4885KDM4E 645/4885
US-11780935-B2 Mutant antibodies and conjugation thereof IGLV6-57, IGSF11, F13B ALDH1A1 3744/4885SMN1; SMN2 2832/4885KDM4E 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.